Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
暂无分享,去创建一个
R. Baron | M. Bouxsein | Yong-ri Jin | C. Rosen | V. Lindner | V. Adarichev | Kenichi Nagano | J. P. Stohn | Qiaozeng Wang
[1] D. Sterchi. Bone , 2019, Bancroft's Theory and Practice of Histological Techniques.
[2] R. Baron,et al. The Actin‐Binding Protein Cofilin and Its Interaction With Cortactin Are Required for Podosome Patterning in Osteoclasts and Bone Resorption In Vivo and In Vitro , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[3] V. Lindner,et al. Collagen triple helix repeat containing 1 is a new promigratory marker of arthritic pannus , 2016, Arthritis Research & Therapy.
[4] L. Liaw,et al. Cthrc1 controls adipose tissue formation, body composition, and physical activity , 2015, Obesity.
[5] Christine W. Duarte,et al. Elevated Plasma Levels of the Pituitary Hormone Cthrc1 in Individuals with Red Hair but Not in Patients with Solid Tumors , 2014, PloS one.
[6] D. Moore,et al. Corrigendum: Ptpn11 deletion in a novel progenitor causes metachondromatosis by inducing hedgehog signalling , 2014, Nature.
[7] D. Ornitz,et al. Osx-Cre Targets Multiple Cell Types besides Osteoblast Lineage in Postnatal Mice , 2014, PloS one.
[8] T. Martin,et al. Coupling the activities of bone formation and resorption: a multitude of signals within the basic multicellular unit. , 2014, BoneKEy reports.
[9] H. Aburatani,et al. Osteoclast-secreted CTHRC1 in the coupling of bone resorption to formation. , 2013, The Journal of clinical investigation.
[10] N. Miyasaka,et al. miR-31 controls osteoclast formation and bone resorption by targeting RhoA , 2013, Arthritis Research & Therapy.
[11] M. Bouxsein,et al. Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[12] O. MacDougald,et al. Marrow fat and bone--new perspectives. , 2013, The Journal of clinical endocrinology and metabolism.
[13] J. Kanis,et al. Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[14] L. Liaw,et al. Cthrc1, a Novel Circulating Hormone Regulating Metabolism , 2012, PloS one.
[15] R. Baron,et al. Energy expenditure and bone formation share a common sensitivity to AP‐1 transcription in the hypothalamus , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[16] R. Kladney,et al. Cathepsin K-Cre Causes Unexpected Germline Deletion of Genes in Mice , 2012, PloS one.
[17] T. Martin,et al. Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis , 2012, Nature Medicine.
[18] L. Maile,et al. Insulin‐like growth factor‐binding protein‐2 is required for osteoclast differentiation , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] M. Schuenke,et al. Collagen Triple Helix Repeat Containing-1 (cthrc1) Attenuates Skeletal Muscle Atrophy: 1757 , 2011 .
[20] V. Vives,et al. The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts , 2011, Journal of Bone and Mineral Research.
[21] Ralph Müller,et al. Guidelines for assessment of bone microstructure in rodents using micro–computed tomography , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[22] C. Ackert-Bicknell,et al. A circadian-regulated gene, Nocturnin, promotes adipogenesis by stimulating PPAR-γ nuclear translocation , 2010, Proceedings of the National Academy of Sciences.
[23] C. Rosen,et al. Fat targets for skeletal health , 2009, Nature Reviews Rheumatology.
[24] A. Klibanski,et al. Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis. , 2009, The American journal of medicine.
[25] J. Deng,et al. Cthrc1 Is a Positive Regulator of Osteoblastic Bone Formation , 2008, PloS one.
[26] Y. Minami,et al. Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex. , 2008, Developmental Cell.
[27] Soo Young Lee,et al. Rac1 GTPase regulates osteoclast differentiation through TRANCE-induced NF-kappa B activation. , 2006, Molecular and cellular biochemistry.
[28] Soo Young Lee,et al. Rac1 GTPase regulates osteoclast differentiation through TRANCE-induced NF-κB activation , 2006, Molecular and Cellular Biochemistry.
[29] L. Liaw,et al. Collagen Triple Helix Repeat Containing 1, a Novel Secreted Protein in Injured and Diseased Arteries, Inhibits Collagen Expression and Promotes Cell Migration , 2005, Circulation research.
[30] S. Cowin,et al. Ultrastructure of the osteocyte process and its pericellular matrix. , 2004, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.
[31] David L. Lacey,et al. Osteoclast differentiation and activation , 2003, Nature.
[32] Steffen Jung,et al. Regulation of Peripheral Lymph Node Genesis by the Tumor Necrosis Factor Family Member Trance , 2000, The Journal of experimental medicine.
[33] S. Morony,et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis , 1999, Nature.